S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Is Graphite the New Lithium? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
New "Mined in America" Lithium Opportunities? (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Is Graphite the New Lithium? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
New "Mined in America" Lithium Opportunities? (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Is Graphite the New Lithium? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
New "Mined in America" Lithium Opportunities? (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Is Graphite the New Lithium? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
New "Mined in America" Lithium Opportunities? (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
NASDAQ:FLGT

Fulgent Genetics (FLGT) Stock Forecast, Price & News

$39.34
-0.58 (-1.45%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$38.50
$40.15
50-Day Range
$28.52
$40.27
52-Week Range
$28.27
$65.17
Volume
323,000 shs
Average Volume
247,371 shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.33

Fulgent Genetics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
7.6% Upside
$42.33 Price Target
Short Interest
Healthy
4.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
1.20mentions of Fulgent Genetics in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.23) to ($1.80) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

693rd out of 1,009 stocks

Medical Laboratories Industry

19th out of 24 stocks


FLGT stock logo

About Fulgent Genetics (NASDAQ:FLGT) Stock

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Stock News Headlines

New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Fulgent Genetics (NASDAQ:FLGT) PT Raised to $37.00
Fulgent Genetics Inc FLGT Stock Quote
See More Headlines
Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Company Calendar

Last Earnings
5/05/2023
Today
5/30/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FLGT
Employees
1,012
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$42.33
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$37.00
Forecasted Upside/Downside
+7.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$143.40 million
Pretax Margin
-10.69%

Debt

Sales & Book Value

Annual Sales
$618.97 million
Cash Flow
$6.57 per share
Book Value
$43.14 per share

Miscellaneous

Free Float
20,268,000
Market Cap
$1.17 billion
Optionable
Not Optionable
Beta
1.55

Social Links


Key Executives

  • Ming HsiehMing Hsieh
    Chairman & Chief Executive Officer
  • James Xie
    President & Chief Operating Officer
  • Paul H. KimPaul H. Kim
    Chief Financial Officer
  • Harry Gao
    Chief Scientific Officer & Laboratory Director
  • Lawrence M. Weiss
    Chief Medical Officer













FLGT Stock - Frequently Asked Questions

Should I buy or sell Fulgent Genetics stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" FLGT shares.
View FLGT analyst ratings
or view top-rated stocks.

What is Fulgent Genetics' stock price forecast for 2023?

3 Wall Street analysts have issued 12-month target prices for Fulgent Genetics' stock. Their FLGT share price forecasts range from $37.00 to $45.00. On average, they predict the company's share price to reach $42.33 in the next year. This suggests a possible upside of 7.6% from the stock's current price.
View analysts price targets for FLGT
or view top-rated stocks among Wall Street analysts.

How have FLGT shares performed in 2023?

Fulgent Genetics' stock was trading at $29.78 at the beginning of the year. Since then, FLGT shares have increased by 32.1% and is now trading at $39.34.
View the best growth stocks for 2023 here
.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a increase in short interest in May. As of May 15th, there was short interest totaling 809,500 shares, an increase of 7.3% from the April 30th total of 754,300 shares. Based on an average daily trading volume, of 229,700 shares, the short-interest ratio is currently 3.5 days. Currently, 4.1% of the shares of the stock are sold short.
View Fulgent Genetics' Short Interest
.

When is Fulgent Genetics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our FLGT earnings forecast
.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics, Inc. (NASDAQ:FLGT) issued its quarterly earnings data on Friday, May, 5th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.68) by $0.21. The firm had revenue of $66.17 million for the quarter, compared to analyst estimates of $61.95 million. Fulgent Genetics had a negative net margin of 7.10% and a negative trailing twelve-month return on equity of 1.05%.

What guidance has Fulgent Genetics issued on next quarter's earnings?

Fulgent Genetics issued an update on its second quarter 2023 earnings guidance on Sunday, May, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $62.00 million-$62.00 million, compared to the consensus revenue estimate of $60.31 million.

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Block (SQ), JD.com (JD), Marvell Technology (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.28%), Dimensional Fund Advisors LP (2.87%), State Street Corp (2.69%), Geode Capital Management LLC (1.36%), JPMorgan Chase & Co. (1.15%) and American Century Companies Inc. (0.94%). Insiders that own company stock include Hanlin Gao, Jian Xie, John C Bolger, Paul Kim and X Cycle LP Tcv.
View institutional ownership trends
.

How do I buy shares of Fulgent Genetics?

Shares of FLGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $39.34.

How much money does Fulgent Genetics make?

Fulgent Genetics (NASDAQ:FLGT) has a market capitalization of $1.17 billion and generates $618.97 million in revenue each year. The company earns $143.40 million in net income (profit) each year or ($0.89) on an earnings per share basis.

How many employees does Fulgent Genetics have?

The company employs 1,012 workers across the globe.

Does Fulgent Genetics have any subsidiaries?
The following companies are subsidiares of Fulgent Genetics: CSI, Cytometry Specialists Inc., FF Gene Biotech, Fulgent Investment Development Limited, Fulgent Therapeutics LLC, and Inform Diagnostics.
Read More
How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The official website for the company is www.fulgentgenetics.com. The company can be reached via phone at (626) 350-0537, via email at nborsje@blueshirtgroup.com, or via fax at 626-454-1667.

This page (NASDAQ:FLGT) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -